News

How to Invest in Ozempic
Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.
Novo Nordisk Stock Drops on Weight-Loss Data. Why Investors Have Doubts.
Novo Nordisk unveiled its latest data for a weight-loss drug candidate, but shares of the maker of Wegovy and Ozempic tumbled ...
EU drugs regulator to allow Novo Nordisk to include heart condition in Ozempic label
Novo Nordisk said on Monday the European drugs regulator will allow a label update for its diabetes drug Ozempic to include a ...
New Atlas3d
Ozempic maker announces not one, but three new weight-loss drugs
Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...
Ozempic-style weight loss drug finally coming to New Zealand
The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...
Novo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints
Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new ...
Pharmabiz1d
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease
CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...
Novo Nordisk preparing to launch weight-loss drug Wegovy in India
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
Deccan Chronicle2d
Novo Nordisk Launches Anti-obesity Drug Wegovy in India
The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...